Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy

ABSTRACT Importance CHD2 is a member of the chromodomain helicase DNA‐binding (CHD) family of proteins, which have important roles in the regulation of gene expression. Dysregulation of this protein may lead to various disorders. Objective To delineate the genotypes and phenotypes of CHD2‐related ep...

Full description

Bibliographic Details
Main Authors: Weixing Feng, Fang Fang, Xiaohui Wang, Chunhong Chen, Junlan Lu, Jie Deng
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Pediatric Investigation
Subjects:
Online Access:https://doi.org/10.1002/ped4.12321
_version_ 1811333594495320064
author Weixing Feng
Fang Fang
Xiaohui Wang
Chunhong Chen
Junlan Lu
Jie Deng
author_facet Weixing Feng
Fang Fang
Xiaohui Wang
Chunhong Chen
Junlan Lu
Jie Deng
author_sort Weixing Feng
collection DOAJ
description ABSTRACT Importance CHD2 is a member of the chromodomain helicase DNA‐binding (CHD) family of proteins, which have important roles in the regulation of gene expression. Dysregulation of this protein may lead to various disorders. Objective To delineate the genotypes and phenotypes of CHD2‐related epilepsy. Methods We analyzed the medical history, magnetic resonance imaging findings, and video‐electroencephalogram recordings of 17 patients with CHD2 mutations in the Neurology Department of Beijing Children's Hospital from June 2016 to June 2021. Results Age at seizure onset ranged from 6 months to 10 years; the median age at onset was 4 years. Generalized tonic‐clonic, myoclonic, eyelid myoclonic, atonic, atypical absence, myoclonic‐atonic, and spasm seizures were observed. Ten of the 17 patients had multiple types of seizures. One patient exhibited photosensitivity epilepsy and one patient exhibited grid image‐induced visual reflex epilepsy. Developmental disability was present in 14 patients, while autism features were present in five patients. Sixteen patients had de novo mutations of CHD2; one patient had an inherited variant. Eleven mutations were novel. One patient had two mutations; that patient exhibited development delay and refractory epilepsy. Seizures were controlled in eight patients, improved in seven patients, and resistant to treatment in two patients. Interpretation Phenotype severity in patients with CHD2 variants ranged from drug‐responsive seizures to severe epileptic encephalopathy. Most patients exhibited developmental disorders.
first_indexed 2024-04-13T16:54:03Z
format Article
id doaj.art-a5ae27c5ab12478f93eb37a1984b74f3
institution Directory Open Access Journal
issn 2574-2272
language English
last_indexed 2024-04-13T16:54:03Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series Pediatric Investigation
spelling doaj.art-a5ae27c5ab12478f93eb37a1984b74f32022-12-22T02:38:51ZengWileyPediatric Investigation2574-22722022-06-0162939910.1002/ped4.12321Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsyWeixing Feng0Fang Fang1Xiaohui Wang2Chunhong Chen3Junlan Lu4Jie Deng5Department of Neurology Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Neurology Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Neurology Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Neurology Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Neurology Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing ChinaDepartment of Neurology Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing ChinaABSTRACT Importance CHD2 is a member of the chromodomain helicase DNA‐binding (CHD) family of proteins, which have important roles in the regulation of gene expression. Dysregulation of this protein may lead to various disorders. Objective To delineate the genotypes and phenotypes of CHD2‐related epilepsy. Methods We analyzed the medical history, magnetic resonance imaging findings, and video‐electroencephalogram recordings of 17 patients with CHD2 mutations in the Neurology Department of Beijing Children's Hospital from June 2016 to June 2021. Results Age at seizure onset ranged from 6 months to 10 years; the median age at onset was 4 years. Generalized tonic‐clonic, myoclonic, eyelid myoclonic, atonic, atypical absence, myoclonic‐atonic, and spasm seizures were observed. Ten of the 17 patients had multiple types of seizures. One patient exhibited photosensitivity epilepsy and one patient exhibited grid image‐induced visual reflex epilepsy. Developmental disability was present in 14 patients, while autism features were present in five patients. Sixteen patients had de novo mutations of CHD2; one patient had an inherited variant. Eleven mutations were novel. One patient had two mutations; that patient exhibited development delay and refractory epilepsy. Seizures were controlled in eight patients, improved in seven patients, and resistant to treatment in two patients. Interpretation Phenotype severity in patients with CHD2 variants ranged from drug‐responsive seizures to severe epileptic encephalopathy. Most patients exhibited developmental disorders.https://doi.org/10.1002/ped4.12321CHD2EpilepsyDevelopmental disabilityPhenotypeSeizure
spellingShingle Weixing Feng
Fang Fang
Xiaohui Wang
Chunhong Chen
Junlan Lu
Jie Deng
Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy
Pediatric Investigation
CHD2
Epilepsy
Developmental disability
Phenotype
Seizure
title Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy
title_full Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy
title_fullStr Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy
title_full_unstemmed Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy
title_short Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy
title_sort clinical analysis of chd2 gene mutations in pediatric patients with epilepsy
topic CHD2
Epilepsy
Developmental disability
Phenotype
Seizure
url https://doi.org/10.1002/ped4.12321
work_keys_str_mv AT weixingfeng clinicalanalysisofchd2genemutationsinpediatricpatientswithepilepsy
AT fangfang clinicalanalysisofchd2genemutationsinpediatricpatientswithepilepsy
AT xiaohuiwang clinicalanalysisofchd2genemutationsinpediatricpatientswithepilepsy
AT chunhongchen clinicalanalysisofchd2genemutationsinpediatricpatientswithepilepsy
AT junlanlu clinicalanalysisofchd2genemutationsinpediatricpatientswithepilepsy
AT jiedeng clinicalanalysisofchd2genemutationsinpediatricpatientswithepilepsy